Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone Dexborneol with Thrombolysis in Acute Ischemic Stroke
NCT05035953Phase 2Unknown
- Sponsor
- Huashan Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of edaravone dexborneol in ischemic stroke, sponsored by Huashan Hospital. Status: unknown.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05035953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035953.